ANRO
Alto Neuroscience
$31.68
−$2.39 (−7.01%)Sep 10, 2026
Key metrics
The numbers that frame ANRO today
- Market cap
- $1.24B
- P/E (TTM)
- -14.8
- EV / FCF
- -14.8
- ROIC
- -404.1%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $3.50
- 52wk High
- $37.48
Growth
Revenue and earnings trend for ANRO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ANRO
Is Alto Neuroscience a good buy?
Hold. Alto Neuroscience has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Alto Neuroscience is selling at a high price.
What is the market capitalization of ANRO?
Alto Neuroscience's market capitalization is $1.24B.
What is the P/E ratio for ANRO stock?
Alto Neuroscience's current P/E ratio is -14.8.
What is the 52-week high for ANRO stock?
The 52-week high for Alto Neuroscience is $37.48. The current close of $31.68 is 15.5% below that high.
What is the 52-week low for ANRO stock?
The 52-week low for Alto Neuroscience is $3.50. The current close of $31.68 is 805.1% above that low.
Does ANRO stock pay dividends?
Alto Neuroscience does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ANRO?
Alto Neuroscience's Debt / Equity ratio is 0.1.